expression by adenovirus type 5 E1A proteins. Mol.
Cell. Biol., 7, 1164-1170 (1987).
15. Yu, D., et al., Transcriptional repression of the neu
protooncogene by the adenovirus 5 E1A products.
Proc. Natl
expression by adenovirus type 5 E1A proteins. Mol.
Cell. Biol., 7, 1164-1170 (1987).
13. Yu, D., et al., Transcriptional repression of the neu
protooncogene by the adenovirus 5 E1A products.
Proc. Natl
developed in rabbit using as immuno-
gen a synthetic peptide corresponding to amino acid
residues 1152-1164 of human hamartin with N-terminal
added Cys-Gly-Gly chain, conjugated to KLH. The
corresponding
and Gilman’s The Pharmacological Basis
of Therapeutics, 9th Ed., Hardman, J.G. et al.,
(Eds.), p. 1164 (McGraw-Hill, New York, NY, 1995).
4. Raleigh, E.A., et al., Selected Topics from Classical
Bacterial
and Gilman’s The Pharmacological Basis
of Therapeutics, 9th Ed., Hardman, J.G. et al.,
(Eds.), p. 1164 (McGraw-Hill, New York, NY, 1995).
4. Raleigh, E.A., et al., Selected Topics from Classical
Bacterial
and Gilman’s The Pharmacological Basis
of Therapeutics, 9th Ed., Hardman, J.G. et al.,
(Eds.), p. 1164 (McGraw-Hill, New York, NY, 1995).
4. Raleigh, E.A., et al., Selected Topics from Classical
Bacterial
Gilman’s The Pharmacological Basis of Therapeutics, 9th Ed., Hardman, J.G. et
al., (Eds.), p. 1164 (McGraw-Hill, New York, NY, 1995).
4. Raleigh, E.A., et al., Selected Topics from Classical Bacterial